How can we support the frontline clinicians and lab professionals with the rapid advances and increases in the demand for cell and gene therapies?
The first step is understanding their experiences and concerns.
This is what we’re hearing:
- Regulatory bodies are constantly changing the standards for the better, but how do we keep up? How do we make sure that we’re doing the exact thing that we’re supposed to be doing?
- A push for decentralized solid manufacturing back into the healthcare spaces means that there’s more complex work that we’re being asked to do. Do we have the tools that we need for that?
- New therapies are constantly being created and new indications are constantly arising. How do I know I’m using the right process for that? How do I know that we’ve got all the tools and the time that I need to deliver therapies to my patients?
- New devices and new equipment, new supplies are constantly in the pipeline. Innovation is at the forefront of everybody’s mind and it should make my work easier and better for the patient. But how do I use them? What does that mean for me and how does that change my process?
The full discussion around improving cell therapy workflows is here.
